SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 197 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $946,000 | -64.4% | 824 | -99.5% | 0.21% | -38.8% |
Q3 2018 | $2,660,000 | +11.3% | 156,913 | -6.7% | 0.34% | -7.9% |
Q2 2018 | $2,389,000 | -55.8% | 168,239 | -40.8% | 0.37% | +14.6% |
Q1 2018 | $5,402,000 | +2699.0% | 284,272 | +349.8% | 0.32% | +2827.3% |
Q4 2016 | $193,000 | +27.0% | 63,204 | +92.7% | 0.01% | +83.3% |
Q3 2016 | $152,000 | -81.3% | 32,804 | -75.6% | 0.01% | -85.4% |
Q1 2016 | $814,000 | -32.0% | 134,500 | +2.6% | 0.04% | -37.9% |
Q4 2015 | $1,197,000 | -51.2% | 131,100 | -69.9% | 0.07% | -34.7% |
Q3 2015 | $2,455,000 | -31.5% | 435,225 | +34.6% | 0.10% | -22.9% |
Q2 2015 | $3,586,000 | -12.0% | 323,390 | +24.5% | 0.13% | -22.9% |
Q1 2015 | $4,073,000 | -8.8% | 259,741 | -11.5% | 0.17% | +20.6% |
Q4 2014 | $4,464,000 | -1.5% | 293,500 | -30.1% | 0.14% | -19.0% |
Q3 2014 | $4,531,000 | -33.1% | 420,123 | -5.2% | 0.17% | -40.0% |
Q2 2014 | $6,769,000 | +111.2% | 443,286 | +150.1% | 0.29% | +61.1% |
Q1 2014 | $3,205,000 | – | 177,265 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
EMC Capital Management | 48,992 | $765,000 | 0.58% |
Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |